4.7 Article

The Research Agenda in ICU Telemedicine A Statement From the Critical Care Societies Collaborative

Journal

CHEST
Volume 140, Issue 1, Pages 230-238

Publisher

AMER COLL CHEST PHYSICIANS
DOI: 10.1378/chest.11-0610

Keywords

-

Funding

  1. National Institutes of Health (NIH)
  2. Society of Critical Care Medicine
  3. American Thoracic Society
  4. Actelion Pharmaceuticals Ltd
  5. Bayer Corporation
  6. Genzyme Corporation
  7. Gilead
  8. Pfizer Inc
  9. Respironics Inc
  10. United Therapeutics Corporation
  11. Pulmonary Association
  12. Blackwell Publishers
  13. UpToDate Inc
  14. Humana Publishers
  15. New England Institute
  16. National Association for Medical Direction of Respiratory Care
  17. Eisai, Inc
  18. Eli Lilly and Company
  19. Journal of the American Medical Association
  20. Wyeth
  21. Novartis Pharmaceuticals Corporation
  22. bioMerieux SA
  23. Roche
  24. CareFusion Corporation
  25. Robert Wood Johnson Foundation
  26. Advanced Lifeline Services, Inc
  27. Siemens Corporation
  28. Byk-Gulden GmbH
  29. AstraZeneca
  30. Faron Pharmaceuticals Ltd
  31. Cerus Corporation
  32. DHD
  33. Hospira, Inc
  34. Cerner Corporation
  35. Kinetic Concepts Inc
  36. American Association for Respiratory Care
  37. Alberta Heritage Foundation for Medical Research
  38. McKesson Corp
  39. Rx Foundation
  40. American Society of Health Systems Pharmacists Foundation
  41. Shared Health (Chattanooga, Tennessee)
  42. Institute for Safe Medication Practice
  43. Canadian Health Services Research Foundation
  44. Alberta Innovates-Health Solution
  45. Canadian Institutes for Health Research
  46. National Institute for Nursing Research (NIH)
  47. Heart and Stroke Foundation of Canada
  48. Ontario Ministry of Health and Long Term Care
  49. Baxter Healthcare
  50. American College of Chest Physicians
  51. US Agency for Healthcare Research and Quality [R13HS19946]

Ask authors/readers for more resources

ICU telemedicine uses audiovisual conferencing technology to provide critical care from a remote location. Research is needed to best define the optimal use of ICU telemedicine, but efforts are hindered by methodological challenges and the lack of an organized delivery approach. We convened an interdisciplinary working group to develop a research agenda in ICU telemedicine, addressing both methodological and knowledge gaps in the field. To best inform clinical decision-making and health policy, future research should be organized around a conceptual framework that enables consistent descriptions of both the study setting and the telemedicine intervention. The framework should include standardized methods for assessing the preimplementation ICU environment and describing the telemedicine program. This framework will facilitate comparisons across studies and improve generalizability by permitting context-specific interpretation. Research based on this framework should consider the multidisciplinary nature of ICU care and describe the specific program goals. Key topic areas to be addressed include the effect of ICU telemedicine on the structure, process, and outcome of critical care delivery. Ideally, future research should attempt to address causation instead of simply associations and elucidate the mechanism of action in order to determine exactly how ICU telemedicine achieves its effects. ICU telemedicine has significant potential to improve critical care delivery, but high-quality research is needed to best inform its use. We propose an agenda to advance the science of ICU telemedicine and generate research with the greatest potential to improve patient care. CHEST 2011; 140(1):230-238

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available